{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:30:20Z","timestamp":1791379820624,"version":"4.3.3"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program","doi-asserted-by":"crossref","award":["2021YFC2300603"],"award-info":[{"award-number":["2021YFC2300603"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shandong Provincial Natural Science Foundation for The Excellent Youth Scholars","award":["ZR2023YQ066"],"award-info":[{"award-number":["ZR2023YQ066"]}]},{"DOI":"10.13039\/501100012152","name":"National Postdoctoral Program for Innovative Talents","doi-asserted-by":"publisher","award":["BX20190192"],"award-info":[{"award-number":["BX20190192"]}],"id":[{"id":"10.13039\/501100012152","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2020M672064"],"award-info":[{"award-number":["2020M672064"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Science Foundation for Young Scientists of China","award":["82001687"],"award-info":[{"award-number":["82001687"]}]},{"name":"the Open Project of State Key Laboratory of Natural Medicines","award":["SKLNMKF202309"],"award-info":[{"award-number":["SKLNMKF202309"]}]},{"name":"the State Key Laboratory of Microbial Technology Open Projects Fund","award":["M2023-13"],"award-info":[{"award-number":["M2023-13"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s00018-024-05404-y","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T02:02:51Z","timestamp":1724810571000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Lymph node-targeted STING agonist nanovaccine against chronic HBV infection"],"prefix":"10.1007","volume":"81","author":[{"given":"Yifei","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiping","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yating","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuju","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6619-8329","authenticated-orcid":false,"given":"Huajun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,28]]},"reference":[{"key":"5404_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41577-021-00549-4","volume":"22","author":"M Iannacone","year":"2022","unstructured":"Iannacone M, Guidotti LG (2022) Immunobiology and pathogenesis of hepatitis B virus infection. Nat Rev Immunol 22:19\u201332","journal-title":"Nat Rev Immunol"},{"key":"5404_CR2","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1001\/jama.2018.3795","volume":"319","author":"LSY Tang","year":"2018","unstructured":"Tang LSY, Covert E, Wilson E, Kottilil S (2018) Chronic Hepatitis B infection: a review. JAMA 319:1802\u20131813","journal-title":"JAMA"},{"key":"5404_CR3","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/S0140-6736(22)01468-4","volume":"401","author":"WJ Jeng","year":"2023","unstructured":"Jeng WJ, Papatheodoridis GV, Lok ASF, Hepatitis B (2023) Lancet 401:1039\u20131052","journal-title":"Lancet"},{"key":"5404_CR4","doi-asserted-by":"publisher","first-page":"881","DOI":"10.3748\/wjg.v28.i9.881","volume":"28","author":"HJ Zhao","year":"2022","unstructured":"Zhao HJ, Hu YF, Han QJ, Zhang J (2022) Innate and adaptive immune escape mechanisms of hepatitis B virus. World J Gastroenterol 28:881\u2013896","journal-title":"World J Gastroenterol"},{"key":"5404_CR5","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3389\/fimmu.2020.00849","volume":"11","author":"P Fisicaro","year":"2020","unstructured":"Fisicaro P, Barili V, Rossi M, Montali I, Vecchi A, Acerbi G et al (2020) Pathogenetic Mechanisms of T Cell Dysfunction in chronic HBV infection and related therapeutic approaches. Front Immunol 11:849","journal-title":"Front Immunol"},{"key":"5404_CR6","doi-asserted-by":"publisher","first-page":"100398","DOI":"10.1016\/j.jhepr.2021.100398","volume":"4","author":"T Vanwolleghem","year":"2021","unstructured":"Vanwolleghem T, Adomati T, Van Hees S, Janssen HLA (2021) Humoral immunity in hepatitis B virus infection: rehabilitating the B in HBV. JHEP Rep 4:100398","journal-title":"JHEP Rep"},{"key":"5404_CR7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1053\/j.gastro.2022.10.008","volume":"164","author":"D Yardeni","year":"2023","unstructured":"Yardeni D, Chang KM, Ghany MG (2023) Current best practice in Hepatitis B Management and understanding long-term prospects for cure. Gastroenterology 164:42\u201360e6","journal-title":"Gastroenterology"},{"key":"5404_CR8","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jhep.2021.11.024","volume":"76","author":"GLH Wong","year":"2022","unstructured":"Wong GLH, Gane E, Lok ASF (2022) How to achieve functional cure of HBV: stopping NUCs, adding interferon or new drug development? J Hepatol 76:1249\u20131262","journal-title":"J Hepatol"},{"key":"5404_CR9","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/s41573-019-0037-0","volume":"18","author":"GC Fanning","year":"2019","unstructured":"Fanning GC, Zoulim F, Hou J, Bertoletti A (2019) Therapeutic strategies for hepatitis B virus infection: towards a cure. Nat Rev Drug Discov 18:827\u2013844","journal-title":"Nat Rev Drug Discov"},{"key":"5404_CR10","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","volume":"21","author":"A Decout","year":"2021","unstructured":"Decout A, Katz JD, Venkatraman S, Ablasser A (2021) The cGAS-STING pathway as a therapeutic target in inflammatory diseases. Nat Rev Immunol 21:548\u2013569","journal-title":"Nat Rev Immunol"},{"key":"5404_CR11","doi-asserted-by":"publisher","first-page":"11420","DOI":"10.1021\/acs.chemrev.9b00833","volume":"120","author":"WH Li","year":"2020","unstructured":"Li WH, Li YM (2020) Chemical strategies to Boost Cancer vaccines. Chem Rev 120:11420\u201311478","journal-title":"Chem Rev"},{"key":"5404_CR12","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/med.21649","volume":"40","author":"JJ Wu","year":"2020","unstructured":"Wu JJ, Zhao L, Hu HG, Li WH, Li YM (2020) Agonists and inhibitors of the STING pathway: potential agents for immunotherapy. Med Res Rev 40:1117\u20131141","journal-title":"Med Res Rev"},{"key":"5404_CR13","doi-asserted-by":"publisher","first-page":"eaau0810","DOI":"10.1126\/science.aau0810","volume":"367","author":"J Wang","year":"2020","unstructured":"Wang J, Li P, Yu Y, Fu Y, Jiang H, Lu M et al (2020) Pulmonary surfactant-biomimetic nanoparticles potentiate heterosubtypic influenza immunity. Science 367:eaau0810","journal-title":"Science"},{"key":"5404_CR14","doi-asserted-by":"publisher","first-page":"eabi9002","DOI":"10.1126\/sciimmunol.abi9002","volume":"6","author":"F Humphries","year":"2021","unstructured":"Humphries F, Shmuel-Galia L, Jiang Z, Wilson R, Landis P, Ng SL et al (2021) A diamidobenzimidazole STING agonist protects against SARS-CoV-2 infection. Sci Immunol 6:eabi9002","journal-title":"Sci Immunol"},{"key":"5404_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41423-021-00801-w","volume":"19","author":"Y Li","year":"2022","unstructured":"Li Y, He M, Wang Z, Duan Z, Guo Z, Wang Z et al (2022) STING signaling activation inhibits HBV replication and attenuates the severity of liver injury and HBV-induced fibrosis. Cell Mol Immunol 19:92\u2013107","journal-title":"Cell Mol Immunol"},{"key":"5404_CR16","doi-asserted-by":"publisher","first-page":"376","DOI":"10.4049\/jimmunol.2000953","volume":"206","author":"E Rodriguez-Garcia","year":"2021","unstructured":"Rodriguez-Garcia E, Zabaleta N, Gil-Farina I, Gonzalez-Aparicio M, Echeverz M, B\u00e4hre H et al (2021) AdrA as a potential Immunomodulatory candidate for STING-Mediated antiviral therapy that required both type I IFN and TNF-\u03b1 production. J Immunol 206:376\u2013385","journal-title":"J Immunol"},{"key":"5404_CR17","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/s41563-022-01251-z","volume":"21","author":"EL Dane","year":"2022","unstructured":"Dane EL, Belessiotis-Richards A, Backlund C, Wang J, Hidaka K, Milling LE et al (2022) STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer immunity. Nat Mater 21:710\u2013720","journal-title":"Nat Mater"},{"key":"5404_CR18","doi-asserted-by":"publisher","first-page":"eaal2094","DOI":"10.1126\/scitranslmed.aal2094","volume":"9","author":"F Liang","year":"2017","unstructured":"Liang F, Lindgren G, Sandgren KJ, Thompson EA, Francica JR, Seubert A et al (2017) Vaccine priming is restricted to draining lymph nodes and controlled by adjuvant-mediated antigen uptake. Sci Transl Med 9:eaal2094","journal-title":"Sci Transl Med"},{"key":"5404_CR19","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1038\/s41423-021-00726-4","volume":"18","author":"J Liu","year":"2021","unstructured":"Liu J, Zhang X, Cheng Y, Cao X (2021) Dendritic cell migration in inflammation and immunity. Cell Mol Immunol 18:2461\u20132471","journal-title":"Cell Mol Immunol"},{"key":"5404_CR20","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/nri2379","volume":"8","author":"P Bousso","year":"2008","unstructured":"Bousso P (2008) T-cell activation by dendritic cells in the lymph node: lessons from the movies. Nat Rev Immunol 8:675\u2013684","journal-title":"Nat Rev Immunol"},{"key":"5404_CR21","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41577-022-00693-5","volume":"22","author":"LSK Walker","year":"2022","unstructured":"Walker LSK (2022) The link between circulating follicular helper T cells and autoimmunity. Nat Rev Immunol 22:567\u2013575","journal-title":"Nat Rev Immunol"},{"key":"5404_CR22","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/s41565-020-0679-4","volume":"15","author":"A Schudel","year":"2020","unstructured":"Schudel A, Chapman AP, Yau MK, Higginson CJ, Francis DM, Manspeaker MP et al (2020) Programmable multistage drug delivery to lymph nodes. Nat Nanotechnol 15:491\u2013499","journal-title":"Nat Nanotechnol"},{"key":"5404_CR23","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41541-021-00330-7","volume":"6","author":"B Nguyen","year":"2021","unstructured":"Nguyen B, Tolia NH (2021) Protein-based antigen presentation platforms for nanoparticle vaccines. NPJ Vaccines 6:70","journal-title":"NPJ Vaccines"},{"key":"5404_CR24","doi-asserted-by":"publisher","first-page":"3714960","DOI":"10.1155\/2018\/3714960","volume":"2018","author":"X Xi","year":"2018","unstructured":"Xi X, Zhang L, Lu G, Gao X, Wei W, Ma G (2018) Lymph Node-Targeting Nanovaccine through Antigen-CpG self-assembly potentiates cytotoxic T cell activation. J Immunol Res 2018:3714960","journal-title":"J Immunol Res"},{"key":"5404_CR25","first-page":"145","volume":"15","author":"Y Xia","year":"2023","unstructured":"Xia Y, Fu S, Ma Q, Liu Y, Zhang N (2023) Application of Nano-Delivery Systems in Lymph Nodes for Tumor Immunotherapy. Nanomicro Lett 15:145","journal-title":"Nanomicro Lett"},{"key":"5404_CR26","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41578-019-0110-7","volume":"4","author":"A Schudel","year":"2019","unstructured":"Schudel A, Francis DM, Thomas SN (2019) Material design for lymph node drug delivery. Nat Rev Mater 4:415\u2013428","journal-title":"Nat Rev Mater"},{"key":"5404_CR27","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41565-020-00790-3","volume":"16","author":"A Singh","year":"2021","unstructured":"Singh A (2021) Eliciting B cell immunity against infectious diseases using nanovaccines. Nat Nanotechnol 16:16\u201324","journal-title":"Nat Nanotechnol"},{"key":"5404_CR28","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41565-020-0648-y","volume":"15","author":"W Wang","year":"2020","unstructured":"Wang W, Zhou X, Bian Y, Wang S, Chai Q, Guo Z et al (2020) Dual-targeting nanoparticle vaccine elicits a therapeutic antibody response against chronic hepatitis B. Nat Nanotechnol 15:406\u2013416","journal-title":"Nat Nanotechnol"},{"key":"5404_CR29","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jconrel.2014.05.029","volume":"193","author":"JV Natarajan","year":"2014","unstructured":"Natarajan JV, Nugraha C, Ng XW, Venkatraman S (2014) Sustained-release from nanocarriers: a review. J Control Release 193:122\u2013138","journal-title":"J Control Release"},{"key":"5404_CR30","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1186\/s12951-022-01577-5","volume":"20","author":"X Ge","year":"2022","unstructured":"Ge X, Hao Y, Li H, Zhao H, Liu Y, Liu Y et al (2022) Sequential acid\/reduction response of triblock copolymeric nanomicelles to release camptothecin and toll-like receptor 7\/8 agonist for orchestrated chemoimmunotherapy. J Nanobiotechnol 20:369","journal-title":"J Nanobiotechnol"},{"key":"5404_CR31","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1136\/gutjnl-2017-315588","volume":"68","author":"HJ Zhao","year":"2019","unstructured":"Zhao HJ, Han QJ, Wang G, Lin A, Xu DQ, Wang YQ et al (2019) Poly I:C-based rHBVvac therapeutic vaccine eliminates HBV via generation of HBV-specific CD8\u2009+\u2009effector memory T cells. Gut 68:2032\u20132043","journal-title":"Gut"},{"key":"5404_CR32","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41423-023-00990-6","volume":"20","author":"A Del Prete","year":"2023","unstructured":"Del Prete A, Salvi V, Soriani A, Laffranchi M, Sozio F, Bosisio D et al (2023) Dendritic cell subsets in cancer immunity and tumor antigen sensing. Cell Mol Immunol 20:432\u2013447","journal-title":"Cell Mol Immunol"},{"key":"5404_CR33","doi-asserted-by":"publisher","first-page":"4184","DOI":"10.4049\/jimmunol.1203449","volume":"191","author":"Z Zeng","year":"2013","unstructured":"Zeng Z, Kong X, Li F, Wei H, Sun R, Tian Z (2013) IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier. J Immunol 191:4184\u20134193","journal-title":"J Immunol"},{"key":"5404_CR34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/hep.30637","volume":"70","author":"A Yonejima","year":"2019","unstructured":"Yonejima A, Mizukoshi E, Tamai T, Nakagawa H, Kitahara M, Yamashita T et al (2019) Characteristics of impaired dendritic cell function in patients with Hepatitis B Virus infection. Hepatology 70:25\u201339","journal-title":"Hepatology"},{"key":"5404_CR35","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1038\/s41423-022-00939-1","volume":"19","author":"H Zhao","year":"2022","unstructured":"Zhao H, Yu Y, Wang Y, Zhao L, Yang A, Hu Y et al (2022) Cholesterol accumulation on dendritic cells reverses chronic hepatitis B virus infection-induced dysfunction. Cell Mol Immunol 19:1347\u20131360","journal-title":"Cell Mol Immunol"},{"key":"5404_CR36","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.3389\/fimmu.2019.01014","volume":"10","author":"R Noubade","year":"2019","unstructured":"Noubade R, Majri-Morrison S, Tarbell KV (2019) Beyond cDC1: emerging roles of DC Crosstalk in Cancer Immunity. Front Immunol 10:1014","journal-title":"Front Immunol"},{"key":"5404_CR37","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/ni.3200","volume":"16","author":"A Schlitzer","year":"2015","unstructured":"Schlitzer A, Sivakamasundari V, Chen J, Sumatoh HR, Schreuder J, Lum J et al (2015) Identification of cDC1- and cDC2-committed DC progenitors reveals early lineage priming at the common DC progenitor stage in the bone marrow. Nat Immunol 16:718\u2013728","journal-title":"Nat Immunol"},{"key":"5404_CR38","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/imr.12640","volume":"283","author":"T Inoue","year":"2018","unstructured":"Inoue T, Moran I, Shinnakasu R, Phan TG, Kurosaki T (2018) Generation of memory B cells and their reactivation. Immunol Rev 283:138\u2013149","journal-title":"Immunol Rev"},{"key":"5404_CR39","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1146\/annurev-immunol-031210-101400","volume":"29","author":"S Crotty","year":"2011","unstructured":"Crotty S (2011) Follicular helper CD4 T cells (TFH). Annu Rev Immunol 29:621\u2013663","journal-title":"Annu Rev Immunol"},{"key":"5404_CR40","doi-asserted-by":"publisher","first-page":"5568","DOI":"10.4049\/jimmunol.1102104","volume":"187","author":"DS McDermott","year":"2011","unstructured":"McDermott DS, Varga SM (2011) Quantifying antigen-specific CD4 T cells during a viral infection: CD4 T cell responses are larger than we think. J Immunol 187:5568\u20135576","journal-title":"J Immunol"},{"key":"5404_CR41","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.4049\/jimmunol.1500839","volume":"195","author":"M Li","year":"2015","unstructured":"Li M, Sun R, Xu L, Yin W, Chen Y, Zheng X et al (2015) Kupffer cells support Hepatitis B virus-mediated CD8\u2009+\u2009T cell exhaustion via Hepatitis B Core Antigen-TLR2 interactions in mice. J Immunol 195:3100\u20133109","journal-title":"J Immunol"},{"key":"5404_CR42","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.3390\/ijms16023307","volume":"16","author":"Y Kondo","year":"2015","unstructured":"Kondo Y, Shimosegawa T (2015) Significant roles of regulatory T cells and myeloid derived suppressor cells in hepatitis B virus persistent infection and hepatitis B virus-related HCCs. Int J Mol Sci 16:3307\u20133322","journal-title":"Int J Mol Sci"},{"key":"5404_CR43","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.3389\/fimmu.2019.02240","volume":"10","author":"K Heim","year":"2019","unstructured":"Heim K, Neumann-Haefelin C, Thimme R, Hofmann M (2019) Heterogeneity of HBV-Specific CD8\u2009+\u2009T-Cell failure: implications for Immunotherapy. Front Immunol 10:2240","journal-title":"Front Immunol"},{"key":"5404_CR44","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1053\/j.gastro.2018.03.021","volume":"154","author":"X Wang","year":"2018","unstructured":"Wang X, Dong Q, Li Q, Li Y, Zhao D, Sun J et al (2018) Dysregulated Response of Follicular Helper T Cells to Hepatitis B Surface Antigen promotes HBV persistence in mice and associates with outcomes of patients. Gastroenterology 154:2222\u20132236","journal-title":"Gastroenterology"},{"key":"5404_CR45","doi-asserted-by":"publisher","first-page":"5461","DOI":"10.4049\/jimmunol.1400849","volume":"193","author":"A Huang","year":"2014","unstructured":"Huang A, Zhang B, Yan W, Wang B, Wei H, Zhang F, Wu L, Fan K, Guo Y (2014) Myeloid-derived suppressor cells regulate immune response in patients with chronic hepatitis B virus infection through PD-1-induced IL-10. J Immunol 193:5461\u20135469","journal-title":"J Immunol"},{"key":"5404_CR46","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/jvh.12255","volume":"21","author":"E Loggi","year":"2014","unstructured":"Loggi E, Gamal N, Bihl F, Bernardi M, Andreone P (2014) Adaptive response in hepatitis B virus infection. J Viral Hepat 21:305\u2013313","journal-title":"J Viral Hepat"},{"key":"5404_CR47","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/s43018-022-00468-w","volume":"3","author":"N Samson","year":"2022","unstructured":"Samson N, Ablasser A (2022) The cGAS-STING pathway and cancer. Nat Cancer 3:1452\u20131463","journal-title":"Nat Cancer"},{"key":"5404_CR48","doi-asserted-by":"publisher","first-page":"795048","DOI":"10.3389\/fimmu.2021.795048","volume":"12","author":"L Ou","year":"2021","unstructured":"Ou L, Zhang A, Cheng Y, Chen Y (2021) The cGAS-STING pathway: a promising Immunotherapy Target. Front Immunol 12:795048","journal-title":"Front Immunol"},{"key":"5404_CR49","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41565-021-00858-8","volume":"16","author":"JJ Rennick","year":"2021","unstructured":"Rennick JJ, Johnston APR, Parton RG (2021) Key principles and methods for studying the endocytosis of biological and nanoparticle therapeutics. Nat Nanotechnol 16:266\u2013276","journal-title":"Nat Nanotechnol"},{"key":"5404_CR50","doi-asserted-by":"publisher","first-page":"10482","DOI":"10.1021\/acsnano.2c01283","volume":"16","author":"M Li","year":"2022","unstructured":"Li M, Liang Z, Chen C, Yu G, Yao Z, Guo Y et al (2022) Virus-like particle-templated silica-adjuvanted nanovaccines with enhanced Humoral and Cellular Immunity. ACS Nano 16:10482\u201310495","journal-title":"ACS Nano"},{"key":"5404_CR51","doi-asserted-by":"publisher","first-page":"7672","DOI":"10.4049\/jimmunol.0902874","volume":"183","author":"D Rai","year":"2009","unstructured":"Rai D, Pham NL, Harty JT, Badovinac VP (2009) Tracking the total CD8 T cell response to infection reveals substantial discordance in magnitude and kinetics between inbred and outbred hosts. J Immunol 183:7672\u20137681","journal-title":"J Immunol"},{"key":"5404_CR52","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.2147\/IJN.S317113","volume":"16","author":"H Zhao","year":"2021","unstructured":"Zhao H, Wang H, Hu Y, Xu D, Yin C, Han Q et al (2021) Chitosan Nanovaccines as efficient carrier adjuvant system for IL-12 with enhanced Protection Against HBV. Int J Nanomed 16:4913\u20134928","journal-title":"Int J Nanomed"},{"key":"5404_CR53","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00018-024-05191-6","volume":"81","author":"G Li","year":"2024","unstructured":"Li G, Zhao X, Zheng Z, Zhang H, Wu Y, Shen Y, Chen Q (2024) cGAS-STING pathway mediates activation of dendritic cell sensing of immunogenic tumors. Cell Mol Life Sci 81:149","journal-title":"Cell Mol Life Sci"},{"key":"5404_CR54","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s41467-022-28197-9","volume":"13","author":"A Lee","year":"2022","unstructured":"Lee A, Scott MKD, Wimmers F, Arunachalam PS, Luo W, Fox CB, Tomai M et al (2022) A molecular atlas of innate immunity to adjuvanted and live attenuated vaccines, in mice. Nat Commun 13:549","journal-title":"Nat Commun"},{"key":"5404_CR55","doi-asserted-by":"publisher","first-page":"114020","DOI":"10.1016\/j.addr.2021.114020","volume":"179","author":"S Van Herck","year":"2021","unstructured":"Van Herck S, Feng B, Tang L (2021) Delivery of STING agonists for adjuvanting subunit vaccines. Adv Drug Deliv Rev 179:114020","journal-title":"Adv Drug Deliv Rev"},{"key":"5404_CR56","doi-asserted-by":"publisher","first-page":"599648","DOI":"10.3389\/fimmu.2020.599648","volume":"11","author":"A Khanam","year":"2021","unstructured":"Khanam A, Ayithan N, Tang L, Poonia B, Kottilil S (2021) IL-21-Deficient T follicular helper cells support B cell responses through IL-27 in patients with chronic Hepatitis B. Front Immunol 11:599648","journal-title":"Front Immunol"},{"key":"5404_CR57","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/s41590-023-01510-4","volume":"24","author":"M K\u00fcnzli","year":"2023","unstructured":"K\u00fcnzli M, Masopust D (2023) CD4\u2009+\u2009T cell memory. Nat Immunol 24:903\u2013914","journal-title":"Nat Immunol"},{"key":"5404_CR58","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-immunol-061020-053702","volume":"39","author":"C Dong","year":"2021","unstructured":"Dong C (2021) Cytokine regulation and function in T cells. Annu Rev Immunol 39:51\u201376","journal-title":"Annu Rev Immunol"},{"key":"5404_CR59","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.celrep.2015.12.006","volume":"14","author":"V Ryg-Cornejo","year":"2016","unstructured":"Ryg-Cornejo V, Ioannidis LJ, Ly A, Chiu CY, Tellier J, Hill DL et al (2016) Severe Malaria infections Impair Germinal Center responses by inhibiting T follicular helper cell differentiation. Cell Rep 14:68\u201381","journal-title":"Cell Rep"},{"key":"5404_CR60","doi-asserted-by":"publisher","first-page":"7239","DOI":"10.1073\/pnas.0502393102","volume":"102","author":"SC Zimmerli","year":"2005","unstructured":"Zimmerli SC, Harari A, Cellerai C, Vallelian F, Bart PA, Pantaleo G (2005) HIV-1-specific IFN-gamma\/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells. Proc Natl Acad Sci U S A 102:7239\u20137244","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5404_CR61","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","volume":"67","author":"European Association for the Study of the Liver","year":"2017","unstructured":"European Association for the Study of the Liver (2017) Electronic address, L. European Association for the study of the, EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol 67:370","journal-title":"J Hepatol"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-024-05404-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-024-05404-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-024-05404-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T03:07:28Z","timestamp":1724814448000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-024-05404-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,28]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["5404"],"URL":"https:\/\/doi.org\/10.1007\/s00018-024-05404-y","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,28]]},"assertion":[{"value":"20 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Institutional Animal Care and Use Committee of Shandong University (approval number: 20023) and were performed in accordance with the Guidelines for the Care and Use of Laboratory Animals and the Ethical Committee of Shandong University. Experiments using samples from human subjects were approved by the Institutional Review Board of Qilu Hospital of Shandong University (approval number: KYLL-2022(ZM)-1414) and conducted in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"was obtained from all participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"372"}}